Literature DB >> 31879484

Effect of local zoledronic acid administration in a rat model of posterolateral spinal fusion.

Ashley Strickland1, Daniel Cavanaugh1, William H Leatherwood1, James Raynor1, Alexander Brown1, Paul S Weinhold1.   

Abstract

STUDY
DESIGN: Randomized animal model study.
PURPOSE: Posterolateral spinal fusion represents a common surgical procedure in the United States. The effect of bisphosphonate administration in these patients is poorly understood. The purpose of this study is to determine whether local administration of bisphosphonate by soaking bone autograft would affect the apparent bone density or structural properties of the fusion mass in a rat model of posterolateral spinal fusion.
METHODS: 36 Spring Dawley rats underwent L4-5 posterolateral spinal fusion with bone autograft. These rats were divided into three groups, two experimental groups and one control group. Each of the experimental groups underwent spinal fusion with morselized vertebral cortical and cancellous autograft soaked in zoledronic acid solution; one group 20 mcg/mL, another 200 mcg/mL. The control group underwent L4-5 spinal fusion with cancellous allograft soaked with saline. At 8 weeks, the rats were euthanized for analysis. Evaluations consisted of micro-CT scanning, four-point bending biomechanical testing, histology, and radiographs.
RESULTS: Both of the experimental groups showed statistically significant increase in apparent bone density and bone volume fraction at the fusion mass. Biomechanical measures revealed a trend for improvement in the experimental groups, but these did not reach statistical significance.
CONCLUSIONS: This data suggest that locally administered bisphosphonate medications result in increased apparent bone density and bone volume fraction at the fusion mass in posterolateral spinal fusion, and that there appear to be no deleterious consequences with regards to the stiffness or maximum load to failure of the fusion mass under flexion bending evaluation.
© 2019 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bisphosphonate; Bone autograft; Rats; Spinal fusion; Zoledronic acid

Year:  2019        PMID: 31879484      PMCID: PMC6919377          DOI: 10.1016/j.jor.2019.08.021

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  15 in total

Review 1.  Guidelines for assessment of bone microstructure in rodents using micro-computed tomography.

Authors:  Mary L Bouxsein; Stephen K Boyd; Blaine A Christiansen; Robert E Guldberg; Karl J Jepsen; Ralph Müller
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

2.  Local alendronic acid elution increases net periimplant bone formation: a micro-CT analysis.

Authors:  J Dennis Bobyn; Rebecca Thompson; Letitia Lim; Jenny Ann Pura; Kristian Bobyn; Michael Tanzer
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

3.  Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo.

Authors:  N Giuliani; M Pedrazzoni; G Negri; G Passeri; M Impicciatore; G Girasole
Journal:  Bone       Date:  1998-05       Impact factor: 4.398

4.  Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.

Authors:  Fabian von Knoch; Claude Jaquiery; Marc Kowalsky; Stefan Schaeren; Claude Alabre; Ivan Martin; Harry E Rubash; Arun S Shanbhag
Journal:  Biomaterials       Date:  2005-12       Impact factor: 12.479

5.  The relationship between serum vitamin D levels and spinal fusion success: a quantitative analysis.

Authors:  Melodie F Metzger; Linda E A Kanim; Li Zhao; Samuel T Robinson; Rick B Delamarter
Journal:  Spine (Phila Pa 1976)       Date:  2015-04-15       Impact factor: 3.468

6.  The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution.

Authors:  Michael Tanzer; Dorota Karabasz; Jan J Krygier; Robert Cohen; J Dennis Bobyn
Journal:  Clin Orthop Relat Res       Date:  2005-12       Impact factor: 4.176

Review 7.  The effect of therapies for osteoporosis on spine fusion: a systematic review.

Authors:  Brandon P Hirsch; Aasis Unnanuntana; Matthew E Cunningham; Joseph M Lane
Journal:  Spine J       Date:  2012-06-01       Impact factor: 4.166

8.  NELL-1 based demineralized bone graft promotes rat spine fusion as compared to commercially available BMP-2 product.

Authors:  Wei Yuan; Aaron W James; Greg Asatrian; Jia Shen; Janette N Zara; Hai Jun Tian; Ronald K Siu; Xinli Zhang; Jeffrey C Wang; Jian Dong
Journal:  J Orthop Sci       Date:  2013-05-18       Impact factor: 1.601

9.  Diminished response to in vivo mechanical loading in trabecular and not cortical bone in adulthood of female C57Bl/6 mice coincides with a reduction in deformation to load.

Authors:  Bettina M Willie; Annette I Birkhold; Hajar Razi; Tobias Thiele; Marta Aido; Bettina Kruck; Alexander Schill; Sara Checa; Russell P Main; Georg N Duda
Journal:  Bone       Date:  2013-05-01       Impact factor: 4.398

10.  Implant-delivered Alendronate Causes a Dose-dependent Response on Net Bone Formation Around Porous Titanium Implants in Canines.

Authors:  Jenny Ann Pura; J Dennis Bobyn; Michael Tanzer
Journal:  Clin Orthop Relat Res       Date:  2016-02-01       Impact factor: 4.176

View more
  1 in total

1.  Topical co-administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment.

Authors:  Hideki Ueyama; Yoichi Ohta; Yuuki Imai; Akinobu Suzuki; Ryo Sugama; Yukihide Minoda; Kunio Takaoka; Hiroaki Nakamura
Journal:  BMC Musculoskelet Disord       Date:  2021-01-20       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.